China Crystal New Material Holdings Co.,Ltd. (KOSDAQ:900250)
1,247.00
+43.00 (3.57%)
At close: Sep 17, 2026
KOSDAQ:900250 Revenue
China Crystal New Material Holdings had revenue of 19.56B KRW in the quarter ending June 30, 2026, with 9.01% growth. This brings the company's revenue in the last twelve months to 70.03B, up 37.85% year-over-year. In the year 2025, China Crystal New Material Holdings had annual revenue of 69.86B with 10.50% growth.
Revenue (ttm)
70.03B
Revenue Growth
+37.85%
P/S Ratio
0.64
Revenue / Employee
n/a
Employees
n/a
Market Cap
44.66B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 69.86B | 6.64B | 10.50% |
| Dec 31, 2024 | 63.22B | -427.06M | -0.67% |
| Dec 31, 2023 | 63.65B | -14.32B | -18.37% |
| Dec 31, 2022 | 77.97B | 15.67B | 25.16% |
| Dec 31, 2021 | 62.30B | -28.54B | -31.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wooree Bio Co.,Ltd | 1.10T |
| Woory Industrial Holdings | 696.68B |
| Wonik Cube | 282.66B |
| Actoz Soft | 74.19B |
| GOODPEOPLE | 70.71B |
| Kyung Nam Pharm | 54.89B |
| JPI Healthcare | 46.86B |
| DYD Co.,LTD. | 44.90B |